Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 87 a 106 di 186
Titolo Data di pubblicazione Autore(i) File
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation 2019 Chen, Fei; Esmaili, Saeed; Rogers, Geraint; Bugianesi, Elisabetta; Petta, Salvatore; Marchesini, Giulio; Bayoumi, Ali; Metwally, Mayada; Azardaryany, Mahmoud Karimi; Coulter, Sally; Choo, Jocelyn M; Younes, Ramy; Rosso, Chiara; Liddle, Christopher; Adams, Leon A; Craxì, Antonio; George, Jacob; Eslam, Mohammed
Leptin receptors on human hepatic stellate cells mediate the expression of proangiogenic cytokines via activation of hypoxia inducile factor 2005 Aleffi S; Bertolani C; Novo E; Parola M; Marra F.
Liver cirrhosis and intrahepatic rennin-angiotensin system: a reappraisal. 2010 Sansoé G; Aragno M; Tomasinelli CE; Mastrocola R; Parola M
Liver production of Endothelin-1 in experimental liver cirrhosis is decreased after neutral endopeptidase system (EC3.4.24.11) inhibition: physiopathological implications 2006 Sansoè GC; Aragno M; Mastrocola R; Rosina F; Smedile A; Rizzetto M; Parola M.
Liver transplantation for patients with HCV-related end-stage liver disease and undetectable HCV-RNA: the Turin Centre experience 2014 Risso, Alessandro; Tandoi, Francesco; Martini, Silvia; Romagnoli, Renato; Salizzoni, Mauro
Local hypothyroidism favours the progression of rat preneoplastic lesions to HCC. 2014 Frau C;Loi R;Petrelli A;Perra A;Menegon S;Kowalik MA;Pinna S;Leoni VP;Fornari F;Gramantieri L;Ledda-Columbano GM;Giordano S;Columbano A
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b. 1993 SARACCO G ;ROSINA F ;ABATE ML ;CHIANDUSSI L ;GALLO V ;CERUTTI E ;DI NAPOLI A ;SOLINAS A ;DEPLANO A ;TOCCO A
The long-term impact of baseline PNPLA3 genotyping in patients with NAFLD. A longitudinal multicentre study 2019 Ramy Younes, Salvatore Petta, Luca Miele, Chiara Rosso, Olivier Govaree, Grazia Pennisi, Paolo Francione, Anna Ludovica Francanzani, Luca Valenti, Ann Daly, Quentin Anstee, Elisabetta Bugianesi
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients 2006 RAIMONDO G; BRUNETTO MR; PONTISSO P; SMEDILE A; MAINA AM; SAITTA C; SQUADRITO G; TONO N
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study 2023 Lee, Jenny; Westphal, Max; Vali, Yasaman; Boursier, Jerome; Petta, Salvatorre; Ostroff, Rachel; Alexander, Leigh; Chen, Yu; Fournier, Celine; Geier, Andreas; Francque, Sven; Wonders, Kristy; Tiniakos, Dina; Bedossa, Pierre; Allison, Mike; Papatheodoridis, Georgios; Cortez-Pinto, Helena; Pais, Raluca; Dufour, Jean-Francois; Leeming, Diana Julie; Harrison, Stephen; Cobbold, Jeremy; Holleboom, Adriaan G; Yki-Järvinen, Hannele; Crespo, Javier; Ekstedt, Mattias; Aithal, Guruprasad P; Bugianesi, Elisabetta; Romero-Gomez, Manuel; Torstenson, Richard; Karsdal, Morten; Yunis, Carla; Schattenberg, Jörn M; Schuppan, Detlef; Ratziu, Vlad; Brass, Clifford; Duffin, Kevin; Zwinderman, Koos; Pavlides, Michael; Anstee, Quentin M; Bossuyt, Patrick M
MAGIC-FACTOR, A PARTIAL AGONIST OF MET, ACTS AS A SAFE HEPATOTROPHIC CYTOKINE 2011 T. Takahara; K. Kawai; T. Sugiyama; M. Asahi; P. Michieli
Matabolomic analysis identifies new biomarkers of liver damage in NAFLD 2014 Ester Vanni; Chiara Rosso; Lavinia Mezzabotta; Chiara Saponaro; Melania Gaggini; Roberto Gambino; Ramy Ibrahim Kamal Jouness; Francesca Saba; Emma Buzzigoli; Fabrizia Carli; Gian Paolo Caviglia; Maria Lorena Abate; Antonina Smedile; Mario Rizzetto; Maurizio Cassader; Amalia Gastaldelli; Elisabetta Bugianesi
The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B 2017 Thabet K.; Chan H.L.Y.; Petta S.; Mangia A.; Berg T.; Boonstra A.; Brouwer W.P.; Abate M.L.; Wong V.W.-S.; Nazmy M.; Fischer J.; Liddle C.; George J.; Eslam M.
Metabolic Syndrome and Severity of Fibrosis in Nonalcoholic Fatty Liver Disease: An Age-Dependent Risk Profiling Study 2016 Petta, Salvatore; Eslam, Mohammed; Valenti, Luca; Bugianesi, Elisabetta; Barbara, Marco; Cammà, Calogero; Porzio, Marianna; Rosso, Chiara; Fargion, Silvia; George, Jacob; Craxì, Antonio
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis 2008 Takahara T; Xue F; Mazzone M; Yata Y; Nonome K; Kanayama M; Kawai K; Pisacane AM; Takahara S; Li XK; Comoglio PM; Sugiyama T; Michieli P
MicroRNA/gene profiling unveils early molecular changes and NRF2 activation in a rat model recapitulating human HCC. 2014 Petrelli A;Perra A;Cora D;Sulas P;Menegon S;Manca C;Migliore C;Kowalik MA;Ledda-Columbano GM;Giordano S;Columbano A
MicroRNAs: New tools for diagnosis, prognosis and therapy in hepatocellular carcinoma? 2013 Giordano S;Columbano A
MiRs*: Innocent bystanders only? 2016 Giordano, Silvia
Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. 1999 SAKAMOTO T.; LIU Z.; MURASE N.; EZURE T.; YOKOMURO S.; V. POLI; DEMETRIS A.J.
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 2017 Kondili L.A.; Romano F.; Rolli F.R.; Ruggeri M.; Rosato S.; Brunetto M.R.; Zignego A.L.; Ciancio A.; Di Leo A.; Raimondo G.; Ferrari C.; Taliani G.; Borgia G.; Santantonio T.A.; Blanc P.; Gaeta G.B.; Gasbarrini A.; Chessa L.; Erne E.M.; Villa E.; Ieluzzi D.; Russo F.P.; Andreone P.; Vinci M.; Coppola C.; Chemello L.; Madonia S.; Verucchi G.; Persico M.; Zuin M.; Puoti M.; Alberti A.; Nardone G.; Massari M.; Montalto G.; Foti G.; Rumi M.G.; Quaranta M.G.; Cicchetti A.; Craxi A.; Vella S.
Mostrati risultati da 87 a 106 di 186
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile